The Future of Hematopoietic Cellular Therapy Lies in
Innovative, Best-in-Class Assays for
High Precision, Reliable Results


Only Preferred Cell Systems™ has the most advanced hematopoietic cellular therapy assays to provide cell processing laboratories with convenient, easy-to-use, rapid and cost-effective testing to help ensure products have the quality and potency necessary for patients.

Preferred Cell Systems™ knows that high quality results can affect a patient's outcome. That's why we guarantee all of our products and provide the highest quality of technical assistance. Contact us today: (719) 264-6251 or info@preferred-cell-systems.com.

 

An Overview and Summary of all Cellular Therapy Assays from Preferred Cell Systems™

 
Assay/Reagent Family Assay Name Description Variations Availability as:
Methylcellulose Assays AllColonies™ Detection of primitive lymph-hematopoietic stem cells AllColonies™ Traditional
AllColonies™ Micro
AllColonies™ Multi
35mm Petri dish assay
Miniaturized assay
96-well plate ATP assay
  ColonyGro™ Detection of hematopoietic progenitor cells Traditional CFU assay 35mm Petri dish format
  CAMEO™-4     Detection of hematopoietic progenitor cells Miniaturized CFU assay 4-well, 35mm Pretri dish assay
         
Growth Medium HemoGro™ Base, serum-free medium for all instrument-based assays   100mL and 500mL
         
Cell Expansion Media CellExpand™ Lympho-hematopoietic cell expansion reagents For multiple cell populations  40mL ready-to-use reagents
         
HALO® Assays     STEMpredict™     3-day stem cell triage quality assay     96- or 384-well assay Standardized ATP bioluminescence
  HALO® QC Cell processing quality control assay 1 or 2 stem cell assay 96-well, standardized ATP bioluminescence
  HALO® SC-IPS Cell potency assay 2 stem cell assay 96-well, standardized ATP bioluminescence
  HALO® TE Time to Engraftment assay     Eythroid and/or granulocyte and/or platelet 96-well, standardized ATP bioluminescence
  HALO® PMT Patient Monitoring after Transplantation 4-Population
5-Population
7-Population
96-well, standardized ATP bioluminescence
         
HemoGLO™ Assays HemoGLO™ PCA Progenitor Cell Assays 96-well ATP bioluminescence (optional standardization)
  HemoGLO™ TE Time to Engraftment assay Eythroid and/or granulocyte and/or platelet 96-well, ATP bioluminescence with optional standardization
  HemoGLO™ PMT
Patient Monitoring after Transplantation
4-Population
5-Population
7-Population
96-well, ATP bioluminescence with optional standardization
         
HemoFLUOR™ Assays HemoFLUOR™ PCA Progenitor Cell Assays 96-well Fluorescence 
  HemoFLUOR™ TE Time to Engraftment assay Eythroid and/or granulocyte and/or platelet 96-well, fluorescence
  HemoFLUOR™ PMT
Patient Monitoring after Transplantation
4-Population
5-Population
7-Population
96-well, fluorescence
  MultiCellGro™ Detection of hematopoietic progenitor cells   96-well, fluorescence
         
Cell Differentiation Media HemaFlo™ Differentiation assay to replace CFU assay Erythroid, granulocyte/macrophage, platelet Detection by flow cytometry
         
HemoLIGHT™ Assays HemoLIGHT™ PCA Progenitor Cell Assays 96-well Absorbance 
  HemoLIGHT™ TE Time to Engraftment assay Eythroid and/or granulocyte and/or platelet 96-well, absorbance
  HemoLIGHT™ PMT
Patient Monitoring after Transplantation
4-Population
5-Population
7-Population
96-well, absorbance

 

Download this Overview and Summary